AlzGene - Gene overview of all published AD-association studies for IL1B
Back Search Methods Disclaimer Credits
 Gene: IL1B  (IL-1B; IL1-Beta; IL1F2; Catabolin)  Entrez Gene    View on MSGene   View on PDGene   View on SZGene
 Protein: interleukin 1, beta   ProteinLink
 Chromosome: 2   (View: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  X  Y  MT)
 Status: Updated 29 January 2010
Meta-Analysis
1. Case-Control Studies (by ethnic group)
      AD Cases Normal Controls    
Study Population Source # Polys # Subjects
(% women)
DX Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result Comment
 Caucasian
Bosco, 2004
Italy    1  (detail)  152
(54%)
C-74.8
(47-99)
136
(55%)
69.3
(55-99)
Positive
Deniz-Naranjo, 2008
Spain CL  1  (detail)  282
(69%)
C--312
(38%)
-Positive
Ehl, 2003
Germany CL  1  (detail)  111
(66%)
C-74.1 + 9.5
(-)
186
(51%)
65.6 + 8.8
(-)
Negative
Giedraitis, 2009
Sweden (ULSAM) CL  1  (detail)  86
(0%)
C80.2
(72-85)
-404
(0%)
81.8
(80-84)
Negative
Green, 2002
UK CL  1  (detail)  294
(64%)
M-63.9 + 6.8
(-)
503
(49%)
62.6 + 5.3
(-)
Negative
Grimaldi, 2000
Italy CL  1  (detail)  318
(63%)
C-66.9 + 9.2
(35-90)
335
(40%)
69.3 + 10.4
(53-98)
Positive
Hedley, 2002
Australia CL  2  (detail)  222
(-)
U--352
(-)
76.6 + 10.2
(-)
Positive
Klimkowicz, 2009
Poland CL  1  (detail)  332
(64%)
C-75.8 + 5.5
(-)
220
(60%)
75.2 + 7.3
(-)
Negative
Licastro, 2000
Overlaps with
Grimaldi, 2000
CL  1  (detail)  281
(61%)
C-74.4 + 1
(-)
201
(32%)
68.9 + 1
(-)
n.a.
Licastro, 2006
Overlaps with
Grimaldi, 2000
CL  1  (detail)  260
(-)
C--190
(-)
-n.a.
Mattila, 2002
Finland CL  1  (detail)  92
(68%)
M-80.5 + 5.5
(-)
73
(47%)
75.3 + 7.5
(-)
Negative
McCulley, 2004
UK CL  1  (detail)  133
(42%)
C73 + 4.2
(-)
78.5 + 6.6
(-)
156
(-)
-Negative
Minster, 2000
USA CL  1  (detail)  335
(65%)
M70.8 + 6.2
(-)
76.9 + 6.4
(-)
205
(70%)
74.1 + 5.9
(-)
Negative
Nicoll, 2000
USA & Europe CL  1  (detail)  233
(-)
N-81.5 + 7.8
(-)
169
(-)
74.4 + 9.6
(-)
Positive
Ravaglia, 2005
Italy CO  1  (detail)  105
(73%)
C-80.6 + 7.8
(-)
644
(52%)
73 + 5.9
(-)
Negative
Rosenmann, 2004
USA CL  1  (detail)  108
(55%)
C72.7
(50-88)
-104
(61%)
77.4
(62-91)
Negative
Sciacca, 2003
Italy CL  1  (detail)  353
(62%)
C-72.8 + 8.7
(-)
482
(50%)
55 + 20.2
(-)
Positive
Seripa, 2005
Italy CL  1  (detail)  237
(68%)
C67
(49-92)
75 + 7.9
(54-90)
147
(64%)
72.1 + 9.1
(58-94)
Positive
Seripa, 2005
USA CL  1  (detail)  124
(54%)
C73
(50-88)
80.9 + 7.6
(64-98)
97
(53%)
84 + 8.6
(65-105)
Negative
Wehr, 2006
Poland CL  2  (detail)  100
(66%)
C-71.8 + 7.9
(52-91)
144
(53%)
70.5 + 8.8
(47-93)
Positive
 Asian
Li, 2004
China CL,PO  1  (detail)  145
(57%)
C69.4 + 9.4
(45-90)
-181
(45%)
69.9 + 7.7
(48-90)
Negative
Ma, 2003
China CL  3  (detail)  90
(76%)
C-77
(61-90)
100
(76%)
73
(61-85)
Negative
Nishimura, 2004
Japan CL  1  (detail)  172
(60%)
C-77.4 + 9.7
(55-96)
163
(61%)
75.5 + 9.9
(-)
Negative
Wang, 2005
Taiwan    2  (detail)  46
(-)
C73.1 + 5.8
(-)
-103
(-)
67.4 + 4.8
(-)
Positive
Wang, 2007
Taiwan CL  1  (detail)  219
(62%)
C-75.6 + 8.3
(-)
209
(46%)
71.2 + 6.7
(-)
Negative
Yucesoy, 2005
USA CO  2  (detail)  179
(0%)
C--517
(0%)
80 + 5.3
(-)
Positive
 Other/Mixed
Oliveira, 2008
Brazil CL  1  (detail)  195
(-)
C-68.7 + 8
(-)
188
(-)
72.3 + 9.7
(-)
Negative
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
2. Family-Based Studies (by ethnic group)
      Affecteds Unaffecteds    
Study Population # Polys # Families # Subjects
(% women)
DX Onset Age
(range)
Age
(range)
# Subjects
(% women)
Age
(range)
Result Comment
 Other/Mixed
Bertram, 2000
USA  1  (detail)  220460
(-)
M--367
(-)
-Negative
Schjeide, 2009
USA (CAG)  1  (detail)  217222
(59%)
M69.2 + 9
(50-89)
-267
(63%)
72.9 + 8.8
(49-92)
Negative
Schjeide, 2009
USA (NCRAD)  1  (detail)  340741
(74%)
M71.3 + 7.6
(50-98)
-300
(55%)
71 + 8.4
(39-93)
Negative
Schjeide, 2009
USA (NIA)  1  (detail)  351803
(64%)
M74.1 + 7.1
(52-98)
-290
(59%)
73.3 + 9.5
(36-94)
Negative
Schjeide, 2009
USA (NIMH)  1  (detail)  436995
(74%)
M72.4 + 7.7
(50-97)
-411
(58%)
70 + 10.7
(31-93)
Negative
Contact us if you are an author of an association study regarding this gene and do not find your study in this table or find errors in the representation of your study details.
Source:  Source of case population -> “CL” (clinic-based), “PO” (population-based), or “CO” (community-based).
# Polys:  Number of polymorphisms tested per gene and per sample.
Onset Age and Age:  Mean or median age at onset or examination, respectively.
DX:  Criteria used to determine AD diagnosis ->  "C" (clinical AD diagnosis), "N" (neuropathological AD diagnosis), "M" (mixed, i.e. AD sample contains both clinical and neuropathological cases), "U" (unknown).
Result:  Overall conclusion reached by authors of the original publication (“positive” usually indicates significant (P<0.05) association in at least one of the performed analyses, and “negative” indicates no evidence for significant association, while “trend” indicates results in between); results obtained in duplicate or largely overlapping samples are listed as "n.a.".
(-) :  Either no data provided or in case of overlap, data included in original study.
AlzGene Recent Updates
AlzGene Top Results
AlzGene Stats
Studies: 1395
Genes: 695
Polymorphisms: 2973
Meta-analyses: 320
Cure Alzheimer's Fund
Proud supporter of the AlzGene database.
Michael J. Fox Foundation
The PDGene database is supported by a grant from The Michael J. Fox Foundation in partnership with the Alzheimer Research Forum.

NCRAD

The National Cell Repository for Alzheimer Disease seeks to recruit 1,000 families with two or more living brothers or sisters who have been diagnosed with late onset Alzheimer’s disease.
ALSGene
AlzGene
MSGene
PDGene
SZGene
An up-to-date collection of all published genetic association studies.